Description
Suitable for
· Cancer patient who seeks guidance for more medication and treatment options
Turn-Around Time (TAT)
· 20 Working Days
Sample Requirement
· 10 mL peripheral blood (Streck CellFree DNA BCT tube)
Screening of 425 genes in cancer-related pathway, 63 hereditary cancer genes, and 182 therapy target genes
Suitable for
· Cancer patient who seeks guidance for more medication and treatment options
Turn-Around Time (TAT)
· 20 Working Days
Sample Requirement
· 10 mL peripheral blood (Streck CellFree DNA BCT tube)